2014
Anti-PR3 and anti-MPO antibodies are not present in sera of patients with pulmonary tuberculosis
Lima I, Oliveira R, Cabral M, Atta A, Marchi S, Reis E, Reis M, Barbosa L, Santiago M. Anti-PR3 and anti-MPO antibodies are not present in sera of patients with pulmonary tuberculosis. Rheumatology International 2014, 34: 1231-1234. PMID: 24719228, DOI: 10.1007/s00296-014-3009-z.Peer-Reviewed Original ResearchConceptsAnti-neutrophil cytoplasmic antibodiesAnti-PR3 antibodiesIndirect immunofluorescencePresence of ANCAPrevalence of ANCAInfectious diseasesComponents of neutrophilsGroup of patientsAnti-MPO antibodiesSera of patientsChest X-rayAnti-PR3Cytoplasmic antibodiesVasculitic syndromesTB patientsPulmonary tuberculosisAutoimmune disordersPresent studyClinical similaritiesSuch antibodiesPatientsELISA kitTuberculosisAntibodiesAutoantibodies
2013
Antibodies to citrullinated peptides in tuberculosis
Lima I, Oliveira R, Atta A, Marchi S, Barbosa L, Reis E, Reis M, Santiago M. Antibodies to citrullinated peptides in tuberculosis. Clinical Rheumatology 2013, 32: 685-687. PMID: 23344687, DOI: 10.1007/s10067-013-2173-y.Peer-Reviewed Original ResearchConceptsAnti-citrullinated peptide antibodiesAnti-MCV antibodiesRheumatoid arthritisHealthy controlsRheumatoid factor positivityRA patientsSymmetric polyarthritisTB patientsPulmonary tuberculosisBone erosionCCP antibodyAutoimmune diseasesHigh incidencePeptide antibodiesPatientsControl groupHigh specificityTuberculosisInfectious diseasesAntibodiesPositivityDiseaseSpecificityMethodological factorsPolyarthritis
2007
Detection of antinucleosome antibodies in systemic lupus erythematosus
Lima I, Barbosa L, Lopes M, Reis E, Reis M, Colossi K, Abreu M, Ferreira C, Santiago M. Detection of antinucleosome antibodies in systemic lupus erythematosus. Advances In Rheumatology 2007, 47: 160-164. DOI: 10.1590/s0482-50042007000300004.Peer-Reviewed Original ResearchDiagnosis of SLESystemic lupus erythematosusSystemic sclerosisDisease activitySLEDAI scoreLupus erythematosusAntinucleosome antibodiesSLE samplesDisease activity indexCross-sectional studyAnti-DNA antibodiesMean age 35Lack of associationMyositis patientsRheumatology criteriaRheumatologic practiceSLE patientsAge 35American CollegeActivity indexPatientsDiagnosisAntibodiesDiagnostic performanceELISA system
1987
Immune serum from both susceptible and resistant strains of mice increases phagocytosis of Leishmania mexicana amazonensis by macrophages.
Reis M, Roters S, Barral-Netto M. Immune serum from both susceptible and resistant strains of mice increases phagocytosis of Leishmania mexicana amazonensis by macrophages. Acta Tropica 1987, 44: 339-42. PMID: 2892370.Peer-Reviewed Original Research